Company Information

Company Merck & Co., Inc.
United States of America
Pharmaceuticals & Biotechnology
Publicly Listed
Global Compact Status:
Participant Since
19 January 2009
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2024

Financial Information

Non-Financial Information

Twitter Feed from Merck & Co., Inc.

Affiliated Subsidiaries

Country Company Name
Serbia Merck Sharp & Dohme d.o.o.

Communication On Progress

Published On Title Level/Status
15-Dec-2023 2023 Communication on Progress Submitted
18-Sep-2022 Communication on Progress Active
16-Sep-2021 Merck 2020/2021 ESG Progress Report Active
15-Oct-2020 2019/2020 Corporate Responsibility Report Active
09-Oct-2019 Communication on Progress Active
09-Oct-2018 Communication on Progress Active
21-Nov-2017 Communication on Progress Active
14-Sep-2017 Grace Letter Not applicable
20-Sep-2016 Communication on Progress Active
05-Oct-2015 Communication on Progress Active
12-Jul-2015 Grace Letter Not applicable
07-Aug-2014 2013 Merck Corporate Responsibility Report Active
07-Aug-2013 Merck 2012 Corporate Responsibility Report Active
13-Sep-2012 Communication on Progress Learner
30-Sep-2011 2011 Communication on Progress Learner
28-Oct-2010 2010 Communication on Progress Not applicable
03-Sep-2010 Grace Letter Not applicable
02-Oct-2009 2008 Corporate Responsibility Report: Advancing the Dialogue Toward a Healthier Future Not applicable

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.